The startups for the 4th round of our Accelerator Program in Darmstadt and the 3rd round in Nairobi are primed and ready to begin their residency at the Innovation Center. In this article, we will introduce the new teams, who will be spending the next three months working on disruptive innovations in the fields of Healthcare, Life Science and Performance Materials. Each startup will get up to 50,000 € in funding, and individual mentoring and coaching from several internal and external experts.
Selecting this round of startups was an especially difficult task. Our selection pool increased by 82% over last year’s, with applicants from over 70 countries. Between our two program locations, seven startups will take part in this round. The topics in Darmstadt vary from solutions from the future of advertising to gamification in oncology. In Nairobi, the teams are tackling issues like data management for global health supply chains and artificial intelligence programs for detecting counterfeit drugs. Continue reading to meet the teams and learn more about them in detail!
The startups from the Accelerator in Darmstadt:
The startups for Nairobi:
RxAll, from New Haven, Connecticut, US, addresses the proliferation of counterfeit drugs which results in about 100,000 deaths in Africa every year. Pharmacists often don’t have the means to test a medicine’s validity. The RxAll team, led by Adebayo Alonge, is developing an AI platform that should solve this problem. Pharmacies will be able to authenticate medicine through the platform, which uses an artificial intelligence with the capacity for deep learning to improve spectrometer readings in the field, providing realtime feedback about changes in drugs. In addition, the pharmacies can order and verify the medicine directly from the manufacturers through a digital procurement platform.